13F-HR filed by Vivo Capital, LLC
Vivo Capital, LLC filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 42 holding rows worth $977,105,491.
- Accession
- 0001213900-25-075901
- Filer
- CIK 1674712
- Filed
- 2025-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 42 entries on the cover page, a total value of $977,105,491 stated on the cover page (in dollars after the unit check, H1), rows summing to $977,105,491 with VALUE read as dollars as filed, 13F file number 028-17467. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SOLENO THERAPEUTICS INC | 834203309 | COM | 3,958,294 | $331,625,871 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 1,393,432 | $131,790,799 | dollars as filed | |
| CIDARA THERAPEUTICS INC | 171757206 | COM NEW | 1,311,425 | $63,879,512 | dollars as filed | |
| GERON CORP | 374163103 | COM | 27,225,292 | $38,387,662 | dollars as filed | |
| SINOVAC BIOTECH LTD | P8696W104 | SHS | 5,903,000 | $38,192,410 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 3,126,604 | $31,735,031 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 6,895,746 | $25,721,133 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 4,487,903 | $24,548,829 | dollars as filed | |
| AVADEL PHARMACEUTICALS PLC | G29687103 | COM SHS | 2,684,109 | $23,754,365 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 434,689 | $23,195,005 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 6,043,466 | $15,713,012 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 982,576 | $13,736,412 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 5,769,230 | $13,096,152 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 8,888,888 | $12,622,221 | dollars as filed | |
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 1,183,260 | $11,465,789 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 1,114,960 | $10,614,419 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 1,842,751 | $10,466,826 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J309 | SPONSORED ADS | 1,054,506 | $9,659,170 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 591,882 | $9,464,193 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 2,112,432 | $9,421,447 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 3,362,385 | $9,414,678 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 2,234,566 | $8,938,264 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 6,756,756 | $8,581,080 | dollars as filed | |
| IO BIOTECH INC | 449778109 | COM | 6,173,439 | $8,581,080 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 1,552,685 | $8,322,392 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 610,500 | $8,150,175 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,122,471 | $8,059,342 | dollars as filed | |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 569,526 | $7,745,554 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 167,600 | $7,047,580 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 251,572 | $6,568,545 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 1,505,862 | $6,414,972 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 1,105,454 | $6,411,633 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 1,538,461 | $6,384,613 | dollars as filed | |
| Instil Bio Inc | 45783C200 | COM NEW | 292,743 | $6,097,837 | dollars as filed | |
| UNICYCIVE THERAPEUTICS INC | 90466Y202 | COMMON STOCK | 1,137,015 | $5,423,562 | dollars as filed | |
| SERA PROGNOSTICS INC | 81749D107 | CMN | 1,650,440 | $4,571,719 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 376,804 | $3,700,215 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 600,000 | $3,072,000 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 260,000 | $2,324,400 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 208,333 | $1,199,998 | dollars as filed | |
| BOLT BIOTHERAPEUTICS INC | 097702203 | COM NEW | 176,064 | $985,958 | dollars as filed | |
| PRECISION BIOSCIENCES INC | 74019P207 | COM NEW | 4,675 | $19,636 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001213900-25-075901 | this filing | 2025-08-14 | acceptance time not in the bulk data set |